封面
市場調查報告書
商品編碼
1458063

生物分析測試服務的全球市場規模、佔有率和成長分析:按工作流程、按測試 - 產業預測(2024-2031)

Global Bioanalytical Testing Services Market Size, Share, Growth Analysis, By Workflow(Sample Preparation, and Sample Analysis), By Test(ADME, PK) - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

生物分析測試服務的全球市場規模預計在2022年達到24.2億美元,從2023年的27.8億美元成長到2031年85.1億美元,預測期內(2024-2031年)複合年成長率為15%。

生物分析測試服務市場旨在為製藥和生物技術公司提供可靠和精確的測試解決方案,以支持安全有效的藥物的開發。全球生物分析測試服務市場的主要促進因素是對藥物開發和監管核准服務的需求不斷成長。隨著製藥和生物技術領域的快速擴張,對可靠、準確的檢測服務的需求不斷增加。然而,全球生物分析測試服務市場面臨的主要挑戰是與這些服務相關的高成本。全球生物分析測試服務市場的一個主要障礙與分析方法和程序缺乏標準化有關。不同服務供應商所採用的方法和程序的差異可能會導致結果不一致以及所產生資料的不可靠性。儘管面臨這些挑戰,全球生物分析測試服務市場為服務供應商提供了許多機會。對個人化醫療和標靶治療的需求迅速成長,推動了對更專業、更量身定做的檢測服務的需求。

目錄

執行摘要

  • 市場概況
  • 命運之輪

調查方法

  • 資訊採購
  • 次要/一級資訊來源
  • 市場規模估算
  • 市場假設與限制

母市場分析

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務

主要市場考察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • Start-Ups分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 監管環境
  • 波特的分析
  • 對未來中斷的特殊考慮

全球生物分析測試服務市場:依工作流程

  • 市場概況
  • 樣品製備
  • 樣品分析

全球生物分析測試服務市場:按測試

  • 市場概況
  • ADME
  • PK
  • PD
  • 生物利用度
  • 生物等效性
  • 其他

全球生物分析測試服務市場規模:按地區分類

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2021年)
  • 主要市場參與者所採取的策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率(2021年)

主要企業簡介

  • Eurofins Scientific SE(Luxembourg)
  • Charles River Laboratories International, Inc.(USA)
  • Laboratory Corporation of America Holdings(USA)
  • WuXi AppTec(China)
  • PPD, Inc.(USA)
  • Frontage Laboratories, Inc.(USA)
  • SGS SA(Switzerland)
  • ICON plc(Ireland)
  • Intertek Group plc(UK)
  • Bioanalytical Systems, Inc.(USA)
  • Almac Group(UK)
  • Anapharm(Canada)
  • Pharmaron Beijing Co., Ltd.(China)
  • Syneos Health(USA)
  • Celerion(USA)
  • BioAgilytix Labs(USA)
  • Medpace Holdings, Inc.(USA)
  • LGC Limited(UK)
  • PSI CRO AG(Switzerland)
  • Bioclinica(USA)
簡介目錄
Product Code: SQMIG35D2157

Global bioanalytical testing services market size was valued at USD 2.42 billion in 2022 and is poised to grow from USD 2.78 billion in 2023 to USD 8.51 billion by 2031, at a CAGR of 15 % during the forecast period (2024-2031).

The bioanalytical testing services market aims to deliver dependable and precise testing solutions to pharmaceutical and biotech firms, aiding them in the development of safe and efficacious drugs. The principal driver behind the global bioanalytical testing services market is the escalating demand for drug development and regulatory approval services. As the pharmaceutical and biotech sectors undergo rapid expansion, there is a growing requirement for trustworthy and accurate testing services. However, the primary challenge for the global bioanalytical testing services market is the high cost associated with these services. A significant hurdle in the global bioanalytical testing services market pertains to the lack of standardization in analytical methods and procedures. Divergence in the methodologies and procedures employed by various service providers may result in inconsistent outcomes, thereby jeopardizing the reliability of the generated data. Despite these challenges, the global bioanalytical testing services market presents several opportunities for service providers. The burgeoning demand for personalized medicine and targeted therapies is propelling the necessity for more specialized and tailored testing services.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioanalytical Testing Services Market Segmental Analysis

The global bioanalytical testing services market is segmented based on workflow, test, and region. By workflow, the market is segmented into sample preparation, and sample analysis. By test, the market is segmented into ADME, PK, PD, bioavailability, bioequivalence, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Bioanalytical Testing Services Market

There is a rising demand for personalized medicine, and bioanalytical testing services are pivotal in the development and evaluation of personalized drugs. These tests are instrumental in assessing the efficacy of drugs on individual patients and assist in determining the most suitable treatment regimen for patients. For example, in 2021, Q^2 Solutions, a leading provider of clinical trials laboratory services globally, broadened its biomarker capabilities to bolster the clinical advancement of personalized medicine. This expansion encompassed the establishment of a cutting-edge flow cytometry laboratory in Scotland, UK.

Restraints in the Global Bioanalytical Testing Services Market

An important factor expected to hinder the growth of the bioanalytical testing services market is the scarcity of qualified individuals proficient in operating the sophisticated equipment essential for conducting bioanalytical tests. According to the US Bureau of Labor Statistics, by 2020, there are projected to be 18,580 vacancies in clinical laboratory science (CLS) programs across the nation. However, only approximately 5,000 students complete accredited CLS programs each year. This indicates that educational programs are producing less than one-third of the necessary trained professionals. Consequently, the adoption of new technologies and methodologies may encounter challenges, potentially constraining the market's future growth.

Market Trends of the Global Bioanalytical Testing Services Market

Pharmaceutical companies are progressively turning to third-party service providers to outsource bioanalytical testing services, aiming to cut costs, enhance efficiency, and concentrate on their core strengths. This outsourcing trend is anticipated to persist in the foreseeable future.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Bioanalytical Testing Services Market by Workflow

  • Market Overview
  • Sample Preparation
  • and Sample Analysis

Global Bioanalytical Testing Services Market by Test

  • Market Overview
  • ADME
  • PK
  • PD
  • Bioavailability
  • Bioequivalence
  • and Others

Global Bioanalytical Testing Services Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi AppTec (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PPD, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Frontage Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intertek Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioanalytical Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Almac Group (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anapharm (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pharmaron Beijing Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syneos Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celerion (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioAgilytix Labs (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medpace Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LGC Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PSI CRO AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioclinica (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments